CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Anticancer activity of a mononuclear Zn(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine against human breast carcinoma cells

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 648
Year: 2014
COI code: CIGS13_0646
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Anticancer activity of a mononuclear Zn(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine against human breast carcinoma cells

  Mohsen Khodayari - Department of Agriculture, Shahid Bahonar University of Kerman, Kerman, Iran.
Masoud Torkzadeh-Mahani - Department of Biotechnology, Institute of Science, High Technology & Environmental Science,Graduate University of Advance Technology, Kerman, Iran.
Keyhaneh Kyani - Department of Biotechnology, Institute of Science, High Technology & Environmental Science,Graduate University of Advance Technology, Kerman, Iran.
  Marzieh Anjomshoa - Department of Chemistry, Shahid Bahonar University of Kerman, Kerman 76169-133, Iran.

Abstract:

In modern medicinal chemistry, transition metal complexes have become suitable candidates as anticancer drugs and chemotherapeutic agents in clinics, the most important examples are cisplatin, carboplatin, and oxaliplatin. Although cisplatin can act as an effective anticancer drug, but use of cisplatin is severely limited by its toxic side-effects. Currentstudies illustrate significant recent development in the field of medicinal bioinorganic chemistry, many new approacheshave been done in order to the design and synthesis of new metal-based anticancer agents with a better biological activity,better selectivity, lower toxicities and different mechanisms of action to overcome the side-effects of cisplatin analoguesdrugs. The main aim of this paper is to study the anticancer properties of the zinc(II) complex, [Zn(dppt)2Cl2] (dppt is 5,6- diphenyl-3-(2-pyridyl)-1,2,4-triazine). The complex has been synthesized and characterized. The cytotoxicity of the complex has been tested against the human breast adenocarcinoma (MCF-7) cell lines by the MTT assay. The concentrationof the Zn(II) complex ranged from 0.05–40 μM. Live cell images were acquired directly using an inverted microscopewithout any treatment or staining. Microscopic analyses of the MCF-7 cells treated with the Zn(II) complex that show thedecreases in the number of the MCF-7 cells with increasing the concentration of the complex. The results of the plot ofpercentage of cytotoxicity vs. concentration of the complex indicate that the complex displays cytotoxicity against human breast cancer cell lines (MCF-7) with an IC50 value of 10.44 μM. It is remarkable that the complex can introduce as a potential anticancer drug.

Keywords:

Zinc(II) complex; 5,6-diphenyl- 3-(2-pyridyl)-1,2,4-triazine(dppt) ; anticancer drug; MCF-7

Perma Link

https://www.civilica.com/Paper-CIGS13-CIGS13_0646.html
COI code: CIGS13_0646

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Khodayari, Mohsen; Masoud Torkzadeh-Mahani; Keyhaneh Kyani & Marzieh Anjomshoa, 2014, Anticancer activity of a mononuclear Zn(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine against human breast carcinoma cells, 12th Congress of Iranian Genetics Society, تهران, انجمن ژنتيك ايران, https://www.civilica.com/Paper-CIGS13-CIGS13_0646.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Khodayari, Mohsen; Masoud Torkzadeh-Mahani; Keyhaneh Kyani & Marzieh Anjomshoa, 2014)
Second and more: (Khodayari; Torkzadeh-Mahani; Kyani & Anjomshoa, 2014)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: state university
Paper No.: 15003
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.